A combined blockade of FMT and PD-1 stimulates mucosal-associated invariant T cells and CD56+CD8+ T cells in peripheral blood mononuclear cells and upregulates human leukocyte antigen class II genes CD74 and GZMK T cells at the tumor site expressing CD8+ T cells [183]. Here, CD8A is linked to neoplasm.